Innovative Bioavailability Assays to Assess the Effectiveness of Contaminated Sediment Remediation (R01)
The summary for the Innovative Bioavailability Assays to Assess the Effectiveness of Contaminated Sediment Remediation (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Bioavailability Assays to Assess the Effectiveness of Contaminated Sediment Remediation (R01): The National Institute of Environmental Health Sciences (NIEHS) invites qualified investigators from domestic institutions of higher education to submit an application for a Superfund Research Program (SRP) Individual Research Project Grant (R01). This funding opportunity announcement (FOA) encourages the research community to develop innovative bioavailability assays to determine the effectiveness of contaminated sediment remediation.
Federal Grant Title: | Innovative Bioavailability Assays to Assess the Effectiveness of Contaminated Sediment Remediation (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Environment Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-ES-11-005 |
Type of Funding: | Grant |
CFDA Numbers: | 93.113 |
CFDA Descriptions: | Environmental Health |
Current Application Deadline: | Feb 17, 2011 |
Original Application Deadline: | Feb 17, 2011 |
Posted Date: | Nov 04, 2010 |
Creation Date: | Nov 04, 2010 |
Archive Date: | Mar 20, 2011 |
Total Program Funding: | $1,160,000 |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...
- • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic ...
- • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)